Jin W. Park
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Synthetic News, Natural Doubts? A Meta-Analysis of Credibility Perceptions of AI-Generated News.
Journal: Cyberpsychology, behavior and social networking
Published: April 07, 2026
Something's Fishy About It: How Opinion Congeniality and Explainability Affect Motivated Attribution to Artificial Intelligence Versus Human Comment Moderators.
Journal: Cyberpsychology, behavior and social networking
Published: June 20, 2022
CD133 increases oxidative glucose metabolism of HT29 cancer cells by mitochondrial uncoupling and its inhibition enhances reactive oxygen species-inducing therapy.
Journal: Nuclear medicine communications
Published: May 23, 2022
89Zr anti-CD44 immuno-PET monitors CD44 expression on splenic myeloid cells and HT29 colon cancer cells.
Journal: Scientific reports
Published: August 07, 2020
89Zr-Labeled Anti-PD-L1 Antibody PET Monitors Gemcitabine Therapy-Induced Modulation of Tumor PD-L1 Expression.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: March 02, 2020
Targeting poor proteasomal function with radioiodine eliminates CT26 colon cancer stem cells resistant to bortezomib therapy.
Journal: Scientific reports
Published: February 18, 2020
Genipin enhances the antitumor effect of elesclomol in A549 lung cancer cells by blocking uncoupling protein-2 and stimulating reactive oxygen species production.
Journal: Oncology letters
Published: January 23, 2020
Study on the effect of a cold environment on the quality of three video laryngoscopes: McGrath MAC, GlideScope Ranger, and Pentax Airway Scope.
Journal: Clinical and experimental emergency medicine
Published: July 26, 2018
ATP-binding Cassette Transporters Substantially Reduce Estimates of ALDH-positive Cancer Cells based on Aldefluor and AldeRed588 Assays.
Journal: Scientific reports
Published: February 15, 2018
Reporter PET Images Bortezomib Treatment-Mediated Suppression of Cancer Cell Proteasome Activity.
Journal: Scientific reports
Published: January 30, 2018
Last Updated: 09/26/2026